search
Back to results

Equity Using Interventions for Pain and Depression - Pilot Study (EQUIPD-Pilot)

Primary Purpose

Chronic Pain, Depression, Health Equity

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Coaching and Decision Aid
Sponsored by
Indiana University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Chronic Pain focused on measuring chronic pain, depression, health equity, shared decision making, decision aid

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Eligible patients must: have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, shoulder) for โ‰ฅ3 months, have at least moderate pain intensity and interference with function, defined by a score โ‰ฅ4 (possible range: 0-10) on the Pain, Enjoyment of Life and General Activity scale (PEG), a 3-item measure of pain intensity, interference with enjoyment of life, and interference with general activity, have at least mild depression, defined as PHQ-8 score โ‰ฅ5, identify as Black, have consistent access to a telephone, indicate openness to new pain treatments, and have a scheduled appointment with their PCP in the next approximate 2-4 months Exclusion Criteria: Patients are excluded: if previously participated in the PI's past pilot study (IRB #12885) or participation as a Patient Engagement Panel member for this project, if medical records indicate severe medical conditions likely precluding participation (e.g., NY Heart Association Class III or IV heart failure), or if the eligibility screener reveals (1) active suicidal ideation, or (2) severe hearing/speech or cognitive impairment.

Sites / Locations

  • Eskenazi Health Primary CareRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Coaching and Decision Aid

Control

Arm Description

Individual coaching sessions and Decision Aid

Wait-list control group

Outcomes

Primary Outcome Measures

Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 3 months
The pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.
Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 6 months
The pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.

Secondary Outcome Measures

Change from Baseline Brief Pain Inventory (BPI) Intensity Scale at 3 months
This pain intensity scale has 4 items with ratings from 0 (no pain) to 10 (pain as bad as you can imagine).
Change from Baseline Brief Pain Inventory (BPI) Intensity Scale at 6 months
This pain intensity scale has 4 items with ratings from 0 (no pain) to 10 (pain as bad as you can imagine).
Change from Baseline Pain Self-Efficacy Questionnaire (PSEQ) at 3 months
This self efficacy questionnaire, developed to assess the confidence people with ongoing pain have in performing activities while in pain, has 10 items with ratings from 0 (not at all confident) to 6 (completely confident).
Change from Baseline Pain Self-Efficacy Questionnaire (PSEQ) at 6 months
This self efficacy questionnaire, developed to assess the confidence people with ongoing pain have in performing activities while in pain, has 10 items with ratings from 0 (not at all confident) to 6 (completely confident).
Change from Baseline Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form at 3 months
The PROMIS Sleep Disturbance Short Form assesses self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep using 6 items with varying 5 point Likert scales.
Change from Baseline Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form at 6 months
The PROMIS Sleep Disturbance Short Form assesses self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep using 6 items with varying 5 point Likert scales.
Change from Baseline Sleep Duration at 3 months
This is a single question asking about the number of hours and minutes of actual sleep in the last month.
Change from Baseline Sleep Duration at 6 months
This is a single question asking about the number of hours and minutes of actual sleep in the last month.
Change from Baseline Patient Health Questionnaire (PHQ)-8 at 3 months
The PHQ-8 is a widely-used, validated 8-item measure of depression severity.
Change from Baseline Patient Health Questionnaire (PHQ)-8 at 6 months
The PHQ-8 is a widely-used, validated 8-item measure of depression severity.
Change from Baseline Generalized Anxiety Disorder (GAD)-7 at 3 months
Anxiety will be measured with the 7 item GAD-7.
Change from Baseline Pain Catastrophizing Scale at 3 months
The Pain Catastrophizing Scale is a 13-item scale that assesses catastrophizing-a cognitive-emotional factor that predicts poor treatment response.
Change from Baseline Pain Catastrophizing Scale at 6 months
The Pain Catastrophizing Scale is a 13-item scale that assesses catastrophizing-a cognitive-emotional factor that predicts poor treatment response.
Change from Baseline Altarum Consumer Engagement (ACE) Measure at 3 months
Patient engagement will be measured with the 12-item Altarum Consumer Engagement (ACE) Measure, which has 3 subscales: 1) commitment to manage one's health, 2) informed choice, and 3) confidence to participate in treatment decisions. Items are assessed on a 5-point Likert scale.
Change from Baseline Altarum Consumer Engagement (ACE) Measure at 6 months
Patient engagement will be measured with the 12-item Altarum Consumer Engagement (ACE) Measure, which has 3 subscales: 1) commitment to manage one's health, 2) informed choice, and 3) confidence to participate in treatment decisions. Items are assessed on a 5-point Likert scale.
Change from Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 3 months
The NSCAP asks about 9 nonpharmacological treatment (NPT) modalities and assesses details of use such as frequency, location/source of service, and patients' judgments of effectiveness. Space is also provided for other NPTs that are used but not listed. The number of modalities for which patients answer "yes" will be summed for analyses.
Change from Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 6 months
The NSCAP asks about 9 nonpharmacological treatment (NPT) modalities and assesses details of use such as frequency, location/source of service, and patients' judgments of effectiveness. Space is also provided for other NPTs that are used but not listed. The number of modalities for which patients answer "yes" will be summed for analyses.
Change from Baseline Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) measure at 3 months
Tobacco, alcohol, and drug use, as well as prescription medication misuse will be assessed using this 4-item screening tool.
Change from Baseline Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) measure at 6 months
Tobacco, alcohol, and drug use, as well as prescription medication misuse will be assessed using this 4-item screening tool.
Change from Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 3 months
Communication self-efficacy will be measured with this 5-item scale that measures patients' self-efficacy in obtaining medical information and getting their most important health concern discussed in a clinic visit.
Change from Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 6 months
Communication self-efficacy will be measured with this 5-item scale that measures patients' self-efficacy in obtaining medical information and getting their most important health concern discussed in a clinic visit.
Change from Baseline CollaboRATE at 3 months
Shared decision making will be measured with CollaboRATE, a 3-item measure assessing provider effort from the patient's perspective to engage in shared-decision making during a recent appointment
Change from Baseline CollaboRATE at 6 months
Shared decision making will be measured with CollaboRATE, a 3-item measure assessing provider effort from the patient's perspective to engage in shared-decision making during a recent appointment
Change from Baseline Working Alliance Inventory (WAI) Client Short Form at 3 months
The Working Alliance Inventory (WAI) Client Short Form assesses patient-provider agreement on treatment goals, collaboration to achieve these goals, and degree of emotional bond (liking and trust) between patients and providers.
Change from Baseline Working Alliance Inventory (WAI) Client Short Form at 6 months
The Working Alliance Inventory (WAI) Client Short Form assesses patient-provider agreement on treatment goals, collaboration to achieve these goals, and degree of emotional bond (liking and trust) between patients and providers.
Perceived Discrimination in Healthcare Scale
We will measure perceived discrimination in healthcare settings with the 7-item "Perceived Discrimination in Healthcare" Scale.
Coaching Satisfaction
We will measure satisfaction with the coaching sessions and coach with 2 questions using a 5-item Likert scale ranging from Very Dissatisfied to Very Satisfied.
Change from Baseline PROMIS Physical Function Short Form 6b at 3 months
Physical functioning will be assessed with the PROMIS Physical Function Short Form 6b which assesses universal physical functioning with a 6-item, self-report scale.
Change from Baseline PROMIS Physical Function Short Form 6b at 6 months
Physical functioning will be assessed with the PROMIS Physical Function Short Form 6b which assesses universal physical functioning with a 6-item, self-report scale.
Change from Baseline Patient Global Impression of Change (PGIC) at 3 months
Patient-reported impression of change will be measured using the PGIC which is a one-item measure reflecting a patient's perception of change after the start of an intervention.
Change from Baseline Patient Global Impression of Change (PGIC) at 6 months
Patient-reported impression of change will be measured using the PGIC which is a one-item measure reflecting a patient's perception of change after the start of an intervention.

Full Information

First Posted
January 11, 2023
Last Updated
September 15, 2023
Sponsor
Indiana University
Collaborators
National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT05695209
Brief Title
Equity Using Interventions for Pain and Depression - Pilot Study
Acronym
EQUIPD-Pilot
Official Title
Equity Using Interventions for Pain and Depression (EQUIPD) - Phase 1
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 22, 2023 (Actual)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
May 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Indiana University
Collaborators
National Institute of Nursing Research (NINR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This pilot randomized controlled trial (RCT) is part of phase 1 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored to Black patients with comorbid chronic pain and depression, to encourage use of and adherence to nonpharmacological pain treatments (NPTs). This 2-arm pilot trial will aim to enroll up to 40 Black patients with comorbid chronic musculoskeletal pain and depression in primary care from an urban safety-net health system with the end goal of at least 30 patients completing the trial. After the baseline assessment, patients randomized to the intervention will be asked to participate in 4 coaching sessions over approximately 12 weeks. Sessions will use Motivational Interviewing principles to foster openness to NPTs and self-efficacy by helping patients identify their goals and priorities, understand their NPT options, prepare them to discuss and choose options with their primary care providers (PCPs), and reinforce these choices to foster maintenance of these changes. DA contents will be integrated into these sessions, which will facilitate discussion of these options with their PCP. The first 3 sessions take place prior to the patient's next scheduled PCP visit; the final session occurs after this visit. Assessments will be conducted at baseline, 3 months (i.e., after completing the final coaching session), and 6 months. Patients randomized to the wait-list control group will receive usual care (in addition to study assessments at baseline, 3 months, and 6 months). After completing the final assessment, they will then be given the DA along with a 20-minute coaching session to walk them through it (patients may decline the coaching session or schedule for a future time).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Pain, Depression, Health Equity
Keywords
chronic pain, depression, health equity, shared decision making, decision aid

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Coaching and Decision Aid
Arm Type
Experimental
Arm Description
Individual coaching sessions and Decision Aid
Arm Title
Control
Arm Type
No Intervention
Arm Description
Wait-list control group
Intervention Type
Behavioral
Intervention Name(s)
Coaching and Decision Aid
Intervention Description
Four (4) coaching sessions over approximately 12 weeks with integration of Decision Aid contents
Primary Outcome Measure Information:
Title
Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 3 months
Description
The pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.
Time Frame
3 months
Title
Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 6 months
Description
The pain interference score averages seven ratings, 0 (does not interfere) to 10 (interferes completely), of interference with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Change from Baseline Brief Pain Inventory (BPI) Intensity Scale at 3 months
Description
This pain intensity scale has 4 items with ratings from 0 (no pain) to 10 (pain as bad as you can imagine).
Time Frame
3 months
Title
Change from Baseline Brief Pain Inventory (BPI) Intensity Scale at 6 months
Description
This pain intensity scale has 4 items with ratings from 0 (no pain) to 10 (pain as bad as you can imagine).
Time Frame
6 months
Title
Change from Baseline Pain Self-Efficacy Questionnaire (PSEQ) at 3 months
Description
This self efficacy questionnaire, developed to assess the confidence people with ongoing pain have in performing activities while in pain, has 10 items with ratings from 0 (not at all confident) to 6 (completely confident).
Time Frame
3 months
Title
Change from Baseline Pain Self-Efficacy Questionnaire (PSEQ) at 6 months
Description
This self efficacy questionnaire, developed to assess the confidence people with ongoing pain have in performing activities while in pain, has 10 items with ratings from 0 (not at all confident) to 6 (completely confident).
Time Frame
6 months
Title
Change from Baseline Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form at 3 months
Description
The PROMIS Sleep Disturbance Short Form assesses self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep using 6 items with varying 5 point Likert scales.
Time Frame
3 months
Title
Change from Baseline Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form at 6 months
Description
The PROMIS Sleep Disturbance Short Form assesses self-reported perceptions of sleep quality, sleep depth, and restoration associated with sleep using 6 items with varying 5 point Likert scales.
Time Frame
6 months
Title
Change from Baseline Sleep Duration at 3 months
Description
This is a single question asking about the number of hours and minutes of actual sleep in the last month.
Time Frame
3 months
Title
Change from Baseline Sleep Duration at 6 months
Description
This is a single question asking about the number of hours and minutes of actual sleep in the last month.
Time Frame
6 months
Title
Change from Baseline Patient Health Questionnaire (PHQ)-8 at 3 months
Description
The PHQ-8 is a widely-used, validated 8-item measure of depression severity.
Time Frame
3 months
Title
Change from Baseline Patient Health Questionnaire (PHQ)-8 at 6 months
Description
The PHQ-8 is a widely-used, validated 8-item measure of depression severity.
Time Frame
6 months
Title
Change from Baseline Generalized Anxiety Disorder (GAD)-7 at 3 months
Description
Anxiety will be measured with the 7 item GAD-7.
Time Frame
3 months
Title
Change from Baseline Pain Catastrophizing Scale at 3 months
Description
The Pain Catastrophizing Scale is a 13-item scale that assesses catastrophizing-a cognitive-emotional factor that predicts poor treatment response.
Time Frame
3 months
Title
Change from Baseline Pain Catastrophizing Scale at 6 months
Description
The Pain Catastrophizing Scale is a 13-item scale that assesses catastrophizing-a cognitive-emotional factor that predicts poor treatment response.
Time Frame
6 months
Title
Change from Baseline Altarum Consumer Engagement (ACE) Measure at 3 months
Description
Patient engagement will be measured with the 12-item Altarum Consumer Engagement (ACE) Measure, which has 3 subscales: 1) commitment to manage one's health, 2) informed choice, and 3) confidence to participate in treatment decisions. Items are assessed on a 5-point Likert scale.
Time Frame
3 months
Title
Change from Baseline Altarum Consumer Engagement (ACE) Measure at 6 months
Description
Patient engagement will be measured with the 12-item Altarum Consumer Engagement (ACE) Measure, which has 3 subscales: 1) commitment to manage one's health, 2) informed choice, and 3) confidence to participate in treatment decisions. Items are assessed on a 5-point Likert scale.
Time Frame
6 months
Title
Change from Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 3 months
Description
The NSCAP asks about 9 nonpharmacological treatment (NPT) modalities and assesses details of use such as frequency, location/source of service, and patients' judgments of effectiveness. Space is also provided for other NPTs that are used but not listed. The number of modalities for which patients answer "yes" will be summed for analyses.
Time Frame
3 months
Title
Change from Baseline Use of Nonpharmacological and Self-Care Approaches (NSCAP) at 6 months
Description
The NSCAP asks about 9 nonpharmacological treatment (NPT) modalities and assesses details of use such as frequency, location/source of service, and patients' judgments of effectiveness. Space is also provided for other NPTs that are used but not listed. The number of modalities for which patients answer "yes" will be summed for analyses.
Time Frame
6 months
Title
Change from Baseline Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) measure at 3 months
Description
Tobacco, alcohol, and drug use, as well as prescription medication misuse will be assessed using this 4-item screening tool.
Time Frame
3 months
Title
Change from Baseline Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) measure at 6 months
Description
Tobacco, alcohol, and drug use, as well as prescription medication misuse will be assessed using this 4-item screening tool.
Time Frame
6 months
Title
Change from Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 3 months
Description
Communication self-efficacy will be measured with this 5-item scale that measures patients' self-efficacy in obtaining medical information and getting their most important health concern discussed in a clinic visit.
Time Frame
3 months
Title
Change from Baseline Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-5) at 6 months
Description
Communication self-efficacy will be measured with this 5-item scale that measures patients' self-efficacy in obtaining medical information and getting their most important health concern discussed in a clinic visit.
Time Frame
6 months
Title
Change from Baseline CollaboRATE at 3 months
Description
Shared decision making will be measured with CollaboRATE, a 3-item measure assessing provider effort from the patient's perspective to engage in shared-decision making during a recent appointment
Time Frame
3 months
Title
Change from Baseline CollaboRATE at 6 months
Description
Shared decision making will be measured with CollaboRATE, a 3-item measure assessing provider effort from the patient's perspective to engage in shared-decision making during a recent appointment
Time Frame
6 months
Title
Change from Baseline Working Alliance Inventory (WAI) Client Short Form at 3 months
Description
The Working Alliance Inventory (WAI) Client Short Form assesses patient-provider agreement on treatment goals, collaboration to achieve these goals, and degree of emotional bond (liking and trust) between patients and providers.
Time Frame
3 months
Title
Change from Baseline Working Alliance Inventory (WAI) Client Short Form at 6 months
Description
The Working Alliance Inventory (WAI) Client Short Form assesses patient-provider agreement on treatment goals, collaboration to achieve these goals, and degree of emotional bond (liking and trust) between patients and providers.
Time Frame
6 months
Title
Perceived Discrimination in Healthcare Scale
Description
We will measure perceived discrimination in healthcare settings with the 7-item "Perceived Discrimination in Healthcare" Scale.
Time Frame
Baseline
Title
Coaching Satisfaction
Description
We will measure satisfaction with the coaching sessions and coach with 2 questions using a 5-item Likert scale ranging from Very Dissatisfied to Very Satisfied.
Time Frame
3 months
Title
Change from Baseline PROMIS Physical Function Short Form 6b at 3 months
Description
Physical functioning will be assessed with the PROMIS Physical Function Short Form 6b which assesses universal physical functioning with a 6-item, self-report scale.
Time Frame
3 months
Title
Change from Baseline PROMIS Physical Function Short Form 6b at 6 months
Description
Physical functioning will be assessed with the PROMIS Physical Function Short Form 6b which assesses universal physical functioning with a 6-item, self-report scale.
Time Frame
6 months
Title
Change from Baseline Patient Global Impression of Change (PGIC) at 3 months
Description
Patient-reported impression of change will be measured using the PGIC which is a one-item measure reflecting a patient's perception of change after the start of an intervention.
Time Frame
3 months
Title
Change from Baseline Patient Global Impression of Change (PGIC) at 6 months
Description
Patient-reported impression of change will be measured using the PGIC which is a one-item measure reflecting a patient's perception of change after the start of an intervention.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Eligible patients must: have musculoskeletal pain in the low back, cervical spine, or extremities (hip, knee, shoulder) for โ‰ฅ3 months, have at least moderate pain intensity and interference with function, defined by a score โ‰ฅ4 (possible range: 0-10) on the Pain, Enjoyment of Life and General Activity scale (PEG), a 3-item measure of pain intensity, interference with enjoyment of life, and interference with general activity, have at least mild depression, defined as PHQ-8 score โ‰ฅ5, identify as Black, have consistent access to a telephone, indicate openness to new pain treatments, and have a scheduled appointment with their PCP in the next approximate 2-4 months Exclusion Criteria: Patients are excluded: if previously participated in the PI's past pilot study (IRB #12885) or participation as a Patient Engagement Panel member for this project, if medical records indicate severe medical conditions likely precluding participation (e.g., NY Heart Association Class III or IV heart failure), or if the eligibility screener reveals (1) active suicidal ideation, or (2) severe hearing/speech or cognitive impairment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer Garabrant
Phone
317-278-2510
Email
jwilkers@iu.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marianne Matthias, PhD
Organizational Affiliation
Indiana University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Eskenazi Health Primary Care
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46254
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer M Garabrant, BSW
Phone
317-278-2510
Email
jwilkers@iu.edu
First Name & Middle Initial & Last Name & Degree
Marianne Matthias, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
NIH intends to maximize the impact of HEAL Initiative-supported projects through broad and rapid data sharing. All HEAL Initiative award recipients, regardless of the amount of direct costs requested for any one year, are required to comply with the HEAL Public Access and Data Sharing Policy, which also aligns with the NIH Policy for Data Management and Sharing (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-013.html). HEAL award recipients must following all requirements and timelines developed through the HEAL Initiative Data Ecosystem, as described in HEAL's compliance guidance (https://heal.nih.gov/data/complying-heal-data-sharing-policy).
IPD Sharing Time Frame
At the time of publication of the primary manuscript
IPD Sharing Access Criteria
Implementation of the plan will follow the HEAL Public Access and Data Sharing Policy.
IPD Sharing URL
https://heal.nih.gov/data/public-access-data

Learn more about this trial

Equity Using Interventions for Pain and Depression - Pilot Study

We'll reach out to this number within 24 hrs